{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:24:42Z","timestamp":1784751882991,"version":"3.55.0"},"reference-count":63,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"7","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>To assess willingness of patients with cancer to participate in observational studies (OBS) and clinical trials (CT) and to examine the factors influencing their decision to join CT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>A cross-sectional study using a systematic sampling strategy was conducted from December 2023 to June 2024. Data were collected directly from patients and their medical charts. Logistic regression was performed to identify significant predictors of patients' willingness to participate in CT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      A total of 367 patients participated, 58.9% were females, and 59.8% had stage IV disease. Most participants (81%) had a performance status (PS) of 0-1, with only 1.9% having prior experience with a CT and 9% with OBS. Willingness to join OBS was higher than willingness to join CT (64%\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      31.6%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). Key barriers included fear of side effects (61.6%), lack of information (46.3%), and concerns about the investigational product (41.6%). Motivators were having their treating physician as the principal investigator (42.5%) and prior human testing of the product (40.6%). Patients who underwent surgery or believed that their physical or psychological condition is unsuitable for trials were less likely to participate (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .05, odds ratio [OR], 0.30, 0.38, 0.37, respectively). Patients with a friend or relative who had joined a trial were more willing to participate (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .05, OR, 3.48).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>The results highlight a low level of willingness to participate in CT. Some barriers could be avoided during the study design phase. Discrepancies between patients' self-assessed PS and physicians' evaluations may lower the enrollment rates. Encouraging patients who have participated in CTs to share their experiences with the family and friends could significantly improve the community's willingness to join CT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-25-00254","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:59:18Z","timestamp":1784750358000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Exploring Factors Affecting Participation in Oncology Clinical Trials in Saudi Arabia: Insights Into Willingness and Barriers"],"prefix":"10.1200","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3500-6050","authenticated-orcid":true,"given":"Mohammad","family":"Alkaiyat","sequence":"first","affiliation":[{"name":"Department of Oncology, Ministry of National Guard\u2014Health Affairs, Riyadh, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Riyadh, Saudi Arabia"},{"name":"King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia"},{"name":"Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6712-7888","authenticated-orcid":true,"given":"Kanan","family":"Alshammari","sequence":"additional","affiliation":[{"name":"Department of Oncology, Ministry of National Guard\u2014Health Affairs, Riyadh, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Riyadh, Saudi Arabia"},{"name":"King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7014-6510","authenticated-orcid":true,"given":"Annibale","family":"Cois","sequence":"additional","affiliation":[{"name":"Burden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa"},{"name":"Division of Epidemiology &amp; Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_7_2_2","first-page":"39","volume-title":"Global Cancer Burden Growing, Amidst Mounting Need for Services","author":"World Health Organization (WHO)","year":"2024","unstructured":"World Health Organization (WHO): Global Cancer Burden Growing, Amidst Mounting Need for Services. International Agency for Research on Cancer 39-42, 2024. https:\/\/www.who.int\/news\/item\/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(01)00486-7"},{"key":"e_1_3_7_4_2","unstructured":"Promoting cancer early diagnosis. https:\/\/www.who.int\/activities\/promoting-cancer-early-diagnosis"},{"key":"e_1_3_7_5_2","first-page":"5232","article-title":"Advances in cancer therapy: Clinical benefit of new cancer drugs","volume":"15","author":"Michaeli DT","year":"2023","unstructured":"Michaeli DT, Michaeli JC, Michaeli T: Advances in cancer therapy: Clinical benefit of new cancer drugs. Aging 15:5232-5234, 2023","journal-title":"Aging"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2011.100"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czq020"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.15537\/1658-3175.5823"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.4553"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)40095-4"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/clinpract12060093"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-019-00959-4"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143893"},{"key":"e_1_3_7_15_2","first-page":"E29959","article-title":"Perceptions and attitudes toward participation in clinical research in the Eastern Mediterranean Region: A systematic review","volume":"101","author":"Aabdien M","year":"2022","unstructured":"Aabdien M, Abdallah I, Bougmiza MI, et al: Perceptions and attitudes toward participation in clinical research in the Eastern Mediterranean Region: A systematic review. Medicine (United States) 101:E29959, 2022","journal-title":"Medicine (United States)"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-014-1339-0"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031305"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9500-y"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2015.09.023"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdp.2005.12.001"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.6245"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_156686"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.3747\/co.24.3662"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270300"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/pon.943"},{"key":"e_1_3_7_26_2","article-title":"Global equity in clinical trials: An ASCO policy statement","author":"Sukhun SAA","unstructured":"Sukhun SAA, Vanderpuye V, Taylor C, et al: Global equity in clinical trials: An ASCO policy statement. JCO Glob Oncol 10.1200\/GO.24.00015","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tipsro.2023.100230"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.107061"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00754"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.e18780"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20792"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.4103\/picr.PICR_177_19"},{"key":"e_1_3_7_33_2","volume-title":"Cancer Incidence Report Saudi Arabia 2020","author":"National Cancer Center","year":"2020","unstructured":"National Cancer Center: Cancer Incidence Report Saudi Arabia 2020. 2020"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S222667"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184428"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.18295\/squmj.11.2021.144"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000531696"},{"key":"e_1_3_7_38_2","first-page":"5","article-title":"The importance of clinical trials for Saudi healthcare","volume":"1","author":"KIMARC","year":"2019","unstructured":"KIMARC: The importance of clinical trials for Saudi healthcare. KIMARC Conf Rep 1:5-7, 2019","journal-title":"KIMARC Conf Rep"},{"key":"e_1_3_7_39_2","first-page":"e17580","article-title":"Willingness and motivation of Saudi patients with keratoconus to participate in clinical trials","volume":"13","author":"Al Mahfud SA","year":"2021","unstructured":"Al Mahfud SA, Al Saeed AA, Alsahly RJ, et al: Willingness and motivation of Saudi patients with keratoconus to participate in clinical trials. Cureus 13:e17580, 2021","journal-title":"Cureus"},{"key":"e_1_3_7_40_2","volume-title":"Knowledge, and Attitudes Towards Clinical Trials in Makkah Region, Saudi Arabia","author":"Basaif EAM","year":"2023","unstructured":"Basaif EAM: Knowledge, and Attitudes Towards Clinical Trials in Makkah Region, Saudi Arabia. Riyadh, Saudi Arabia, Alfaisal University, 2023"},{"key":"e_1_3_7_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10943-016-0306-8"},{"key":"e_1_3_7_42_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.31.15_suppl.e17528"},{"key":"e_1_3_7_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13187-015-0797-0"},{"key":"e_1_3_7_44_2","first-page":"1","article-title":"Knowledge and attitudes regarding clinical trial participation: A cross-sectional Study in the Eastern Province, Saudi Arabia","volume":"15","author":"Almaqhawi A","year":"2023","unstructured":"Almaqhawi A, AlHussain AK, Alharbi M, et al: Knowledge and attitudes regarding clinical trial participation: A cross-sectional Study in the Eastern Province, Saudi Arabia. Cureus 15:1-11, 2023","journal-title":"Cureus"},{"key":"e_1_3_7_45_2","volume-title":"King Abdulaziz Medical City in Riyadh","author":"Affairs M.","year":"2019","unstructured":"Affairs, M. of N. G.\u2014H. King Abdulaziz Medical City in Riyadh. Ministry of National Guard\u2014Health Affairs. 2019. https:\/\/www.mngha.med.sa\/English\/MedicalCities\/AlRiyadh\/Pages\/default.aspx"},{"key":"e_1_3_7_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_3_7_47_2","first-page":"44","article-title":"Cancer clinical trials\u2014Survey evaluating patient participation and acceptance in a university-based Comprehensive Cancer Center (CCC)","volume":"13","author":"Kessel KA","year":"2018","unstructured":"Kessel KA, Vogel MM, Kessel C, et al: Cancer clinical trials\u2014Survey evaluating patient participation and acceptance in a university-based Comprehensive Cancer Center (CCC). Clin Transl Radiat Oncol 13:44-49, 2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"e_1_3_7_48_2","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2012.031"},{"key":"e_1_3_7_49_2","volume-title":"IBM SPSS Statistics for Windows, Version 26.0","author":"IBM Corp","year":"2019","unstructured":"IBM Corp: IBM SPSS Statistics for Windows, Version 26.0. 2019"},{"key":"e_1_3_7_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03561.x"},{"key":"e_1_3_7_51_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-020-00979-z"},{"key":"e_1_3_7_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2016.03.005"},{"key":"e_1_3_7_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21164"},{"key":"e_1_3_7_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6905"},{"key":"e_1_3_7_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70576-9"},{"key":"e_1_3_7_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy221"},{"key":"e_1_3_7_57_2","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181fb50d8"},{"key":"e_1_3_7_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24527"},{"key":"e_1_3_7_59_2","volume-title":"Drug Clinical Trials List","author":"Saudi Food and Drug Authority","unstructured":"Saudi Food and Drug Authority: Drug Clinical Trials List. https:\/\/www.sfda.gov.sa\/en\/drug_clinical_trials_list?title=breast+cancer+&field_drug_study_value=&field_drug_sponsor_value=&field_drug_protocol_number_value=&field_drug_phase_n_target_id=All&field_drug_status_value=All&field_drug_trial_site_value="},{"key":"e_1_3_7_60_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.e18899"},{"key":"e_1_3_7_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2024.108358"},{"key":"e_1_3_7_62_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-10-792"},{"key":"e_1_3_7_63_2","doi-asserted-by":"publisher","DOI":"10.1080\/10810730.2015.1018599"},{"key":"e_1_3_7_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5150"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-25-00254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:59:26Z","timestamp":1784750366000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-25-00254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1200\/GO-25-00254"],"URL":"https:\/\/doi.org\/10.1200\/go-25-00254","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2025-05-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500254"}}